What is the main focus of India's Union Budget 2026 for health policy?

The Union Budget 2026 focuses on transforming India into a credible hub for biologics and biosimilars, alongside strengthening clinical trials, regulatory infrastructure, and preventive care.

What is the Biopharma SHAKTI initiative?

Biopharma SHAKTI is a headline announcement of Budget 2026 with an outlay of ₹10,000 crore over five years, aimed at enhancing domestic manufacturing capabilities in the biopharma sector.

How does Budget 2026 address service delivery and healthcare workforce?

The budget proposes establishing NIMHANS-2, expanding emergency and trauma care, and adding 100,000 Allied Health Professionals to improve service delivery and workforce capacity.

Home / Business and Economy / India's Health Budget 2026: A Biopharma Revolution

India's Health Budget 2026: A Biopharma Revolution

16 Feb

•

Summary

Budget aims to transform India into a biologics and biosimilars hub.
Biopharma SHAKTI initiative receives ₹10,000 crore over five years.
Focus on preventive care, mental health, and emergency services.

India's Health Budget 2026: A Biopharma Revolution

Union Budget 2026 signals a major pivot in India's health policy, focusing on building a full stack for an innovation-led, patient-centered health economy. The government aims to elevate India from a generics-first market to a credible hub for biologics and biosimilars.

This strategic direction aligns with the growing burden of non-communicable diseases, which now account for over 57 percent of all deaths in India. The budget reinforces a shift towards prevention and early intervention, addressing lifestyle-driven health risks.